Dynamic regulation of CD45 by tetraspanin CD53

Abstract

T cells are central to the adaptive immune response, playing a role in both the direct and indirect killing of pathogens and transformed cells. The activation of T cells is the result of a complex signaling cascade, initiated at the T cell receptor (TCR), and ending with the induction of proliferation. CD45, a member of the protein tyrosine phosphatase family, is one of the most abundant membrane proteins on T cells and functions by regulating activation directly downstream of the TCR. As a result of alternative splicing, CD45 can be expressed in multiple isoforms, naive T cells express the CD45RA isoform, while activated T cells gain expression of CD45RO, which has been proposed to increase signaling. Though the importance of CD45 in TCR signaling, proliferation and cytokine production is well established, little is known about the regulation of CD45 activity. We discovered that the immune-specific tetraspanin CD53 directly affects the stability and function of CD45RO in T cells. We have identified CD53 as a T cell co-stimulatory molecule in primary human and murine cells. Furthermore, we have shown that the absence of CD53 leads to an altered CD45 isoform expression as a result of decreased CD45RO stability on the cell surface. This instability was accompanied by increased mobility as measured by FRAP. Together, this indicates that CD53 functions as a stabilizer of CD45RO, and therefore as a positive regulator of TCR signaling at the T cell surface. Our data provides novel insight into the role of tetraspanins in the regulation of immune signaling and may provide a new avenue for the regulation of T cell signaling.

A deep profile of gene expression across 18 human cancers

“…In addition to IL10RA, DeepProfile’s top attributions contained many lesser known but potentially important genes that are consistently involved in the latent spaces of most cancer types. These included CD53, an immune-cell specific tetraspanin 36 ; EVI2A and EVI2B, genes that control granulocytic differentiation 37 ; and TYROBP, an adaptor protein that in association with various receptors mediates immune cell activation 38 ( Figure 3A ). As indicated above, none of these genes appear to signal the presence of a particular immune cell type in the tumor microenvironment, as they are broadly expressed by many different cells, but instead may be involved in modulating tumor-resident immune cells’ transcriptional phenotypes.…”

Uncovering key molecules and immune landscape in cholestatic liver injury: implications for pathogenesis and drug therapy

“…In the present study, we found eight key genes involved in cholestasis, and all of them were highly immune-associated. Among them, SYK, PTPRC, TYROBP, LCP2, and CD53 are preferentially expressed on various adaptive immune cells, playing an important role in the activation of T cells and B cells (Donovan and Koretzky, 1993;Cornall et al, 2000;Dunlock et al, 2022;Iyer et al, 2022). Simultaneously, emerging evidence showed that SYK was required for monocyte adhesion (Chang et al, 2012) and was related to the phenotype switch of monocyte-derived macrophages (Chen et al, 2021), playing an indispensable role in innate immunity.…”